Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 132
Filter
1.
Virchows Arch ; 470(4): 421-428, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28204871

ABSTRACT

The WHO classification of testis tumours includes the group of sex cord-stromal tumours. They are divided into several histological types, i.e. Leydig cell (LCT) and Sertoli cell tumours (SCT). Based on the physiological expression of ß-catenin in normal testis/Sertoli cells, it was previously shown that SCT can carry a ß-catenin mutation, causing a nuclear positivity for ß-catenin and cyclin D1. Furthermore, it could be shown that the stabilization of ß-catenin in Sertoli cells causes the loss of the Sertoli cell marker SOX9. We wanted to know whether the stabilization of ß-catenin in sex cord-stromal tumours influences SOX-9 expression and thus could be used in the diagnosis of sex cord-stromal tumours. Therefore, 53 cases of sex cord-stromal tumours and tumour-like lesions were investigated for their immunohistochemical expressions of ß-catenin, cyclin D1 and SOX9. In addition, mutation analyses of the ß-catenin gene (exon 3; CTNNB1) were performed. ß-catenin mutation in SCT results in nuclear ß-catenin and cyclin-D1 expressions on immunohistochemical analysis. The nuclear expression/stabilization of ß-catenin causes the loss of SOX9 in these tumours. In contrast, SOX9 is considerably expressed in non-mutated SCT as well as in Sertoli cells of non-neoplastic testes. In summary, immunohistochemical analyses of ß-catenin and SOX9 are useful to distinguish SCT from other sex cord-stromal tumours of the testis. Furthermore, the presence of SOX9 indicates that the cells of origin may be Sertoli cells.


Subject(s)
Biomarkers, Tumor/analysis , SOX9 Transcription Factor/biosynthesis , Sex Cord-Gonadal Stromal Tumors/diagnosis , Testicular Neoplasms/diagnosis , beta Catenin/biosynthesis , Adolescent , Adult , Aged , Aged, 80 and over , DNA Mutational Analysis , Humans , Immunohistochemistry , Male , Middle Aged , Mutation , SOX9 Transcription Factor/analysis , Sex Cord-Gonadal Stromal Tumors/genetics , Sex Cord-Gonadal Stromal Tumors/metabolism , Testicular Neoplasms/genetics , Testicular Neoplasms/metabolism , beta Catenin/analysis
2.
Pathologe ; 36(5): 432-42, 2015 Sep.
Article in German | MEDLINE | ID: mdl-26310365

ABSTRACT

The macrophage cell system was identified by Metchnikoff on the basis of its phagocytic ability. Later on, the reticulohistiocytic system was defined as being composed of antigen-presenting reticulum cells and macrophages. Van Furth proposed that the mononuclear phagocyte system includes all tissue macrophages as well as antigen-presenting cells and blood monocytes as their precursors. Recent findings have shown that blood monocytes are not just transient forms involved in the recruitment of macrophages but that different dendritic and monocytic subpopulations can be observed in blood. In tissue, self-renewing macrophages derived from the yolk sac as well as monocyte-derived dendritic cells and monocyte-derived macrophages can be distinguished. Due to their plasticity and polarization, under inflammatory conditions monocyte-derived macrophages may be beneficial for the reestablishment of homeostasis or may contribute to mostly chronic diseases. Because of their ubiquitous distribution, monocytes and macrophages are increasingly considered to be possible therapeutic targets.


Subject(s)
Macrophages/immunology , Macrophages/pathology , Monocytes/immunology , Monocytes/pathology , Phagocytes/pathology , Antigen-Presenting Cells/physiology , Cell Differentiation/physiology , Cell Transformation, Neoplastic/pathology , Dendritic Cells/immunology , Humans , Phagocytosis/immunology
3.
Pathologe ; 35(3): 245-51, 2014 May.
Article in German | MEDLINE | ID: mdl-24819979

ABSTRACT

According to the World Health Organization (WHO) classification from 2004, sex cord gonadal stromal tumors are divided into Leydig cell tumors, Sertoli cell tumors, granulosa cell tumors, tumors of the thecoma-fibroma group, incompletely differentiated sex cord gonadal stromal tumors, mixed forms of sex cord gonadal stromal tumors and tumors containing both germ cell and sex cord gonadal stromal elements. These tumors can appear sporadically or in combination with hereditary syndromes. To diagnose these rare tumors the combination of characteristic morphological aspects and various immunohistochemical markers is useful. Latest investigations demonstrate the potential role of mutation analyses in the diagnosis of this heterogeneous group of tumors.


Subject(s)
Sex Cord-Gonadal Stromal Tumors/pathology , Testicular Neoplasms/pathology , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , DNA Mutational Analysis , Diagnosis, Differential , Fibroma/genetics , Fibroma/pathology , Granulosa Cell Tumor/genetics , Granulosa Cell Tumor/pathology , Humans , Leydig Cell Tumor/genetics , Leydig Cell Tumor/pathology , Male , Prognosis , Sertoli Cell Tumor/genetics , Sertoli Cell Tumor/pathology , Sex Cord-Gonadal Stromal Tumors/genetics , Testicular Neoplasms/genetics , Testis/pathology , Thecoma/genetics , Thecoma/pathology
4.
Exp Mol Pathol ; 95(3): 307-12, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24076247

ABSTRACT

Myoglobin is a member of the hemoprotein superfamily, which additionally includes hemoglobin, neuroglobin and cytoglobin. Cytoplasmic localized myoglobin functions as a radical scavenger and prevents hypoxia. Besides muscle tissue MB expression could also be observed in other tissues as well as in different types of cancer. For the correlation between the expression of myoglobin, hypoxia-inducible-factor-1α, and capillary density tissue of 86 different renal cell carcinomas were immunohistochemically stained with myoglobin-specific and hypoxia-inducible-factor-1α-specific antibodies as well as with CD31 antibody. Four different renal carcinoma cell lines were cultivated under hypoxic conditions and the expression of myoglobin and hypoxia-inducible-factor-1α was evaluated by real-time PCR and Western blot. Renal cell carcinoma including clear cell, papillary, and chromophobe subtypes expressed myoglobin with an inverse relationship to capillary density being highly significant for clear cell renal cell carcinoma. For hypoxia-inducible-factor-1α a significant correlation with capillary density could also be observed in clear cell RCC. In renal cell carcinoma cell lines hypoxia induced a significant increase of myoglobin expression up to 62 fold, whereas hypoxia-inducible-factor-1α only increased up to 5 fold. The PCR results of myoglobin expression could be confirmed by Western blot. Myoglobin seems to be a sensitive marker for hypovascularized tumor entities especially during the early phase of hypoxia. Such neoplasias may benefit from an antiangiogenic therapy.


Subject(s)
Carcinoma, Papillary/pathology , Carcinoma, Renal Cell/pathology , Gene Expression Regulation, Neoplastic , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Hypoxia/pathology , Kidney Neoplasms/pathology , Myoglobin/metabolism , Apoptosis , Blotting, Western , Carcinoma, Papillary/genetics , Carcinoma, Papillary/metabolism , Carcinoma, Renal Cell/genetics , Carcinoma, Renal Cell/metabolism , Cell Proliferation , Female , Humans , Hypoxia/genetics , Hypoxia/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Immunoenzyme Techniques , Kidney Neoplasms/genetics , Kidney Neoplasms/metabolism , Male , Middle Aged , Myoglobin/genetics , Neoplasm Staging , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
5.
APMIS ; 121(10): 976-81, 2013 10.
Article in English | MEDLINE | ID: mdl-23398382

ABSTRACT

Leydig cell tumours comprise about 3% of all testicular tumours. The pathogenesis of Leydig cell tumours is still poorly understood. We investigated testis with Leydig cell hyperplasia and Leydig cell tumours for their expression pattern of P- and N-cadherin. We could show a switch of expression of P- and N-cadherin in Leydig cell hyperplasia and Leydig cell tumours in comparison with normal Leydig cells. Cadherins could be established as a new immunohistochemical marker for this testicular tumour entity; their possible role in tumour genesis will be discussed.


Subject(s)
Antigens, CD/genetics , Cadherins/genetics , Hyperplasia/genetics , Leydig Cell Tumor/genetics , Leydig Cells/metabolism , Testicular Neoplasms/genetics , Adult , Antigens, CD/metabolism , Cadherins/metabolism , Case-Control Studies , Diagnosis, Differential , Gene Expression , Humans , Hyperplasia/diagnosis , Hyperplasia/metabolism , Hyperplasia/pathology , Leydig Cell Tumor/diagnosis , Leydig Cell Tumor/metabolism , Leydig Cell Tumor/pathology , Leydig Cells/pathology , Male , Middle Aged , Testicular Neoplasms/diagnosis , Testicular Neoplasms/metabolism , Testicular Neoplasms/pathology
6.
Anticancer Res ; 32(1): 341-9, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22213325

ABSTRACT

Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18-35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. 1,25-Dihydroxyvitamin D (1,25(OH)(2)D(3)) is the active form of vitamin D and exerts its actions via a specific intracellular vitamin D receptor (VDR). Several investigations in the recent years have revealed, in addition to a physiological occurrence of the VDR in various tissues, VDR expression in different human malignancies. Furthermore, 1,25(OH)(2)D(3) plays an important role in the regulation of cell proliferation and differentiation. In different normal and malignant cell types, antiproliferative and pro-differentiating effects of 1,25(OH)(2)D(3) are described. We investigated whether TGCT express the VDR, wether differences exist between the histological subtypes and if vitamin D has a function on the proliferation of tumour cells. Furthermore, we investigated the potential function of the vitamin D-regulated genes nuclear receptor co-repressor 1(NCOR1), nuclear receptor co-repressor 2 (NCOR2), thyroid receptor interacting protein 15 (TRIP15), Growth Arrest and DNA Damage (GADD45), MAP kinase-activated protein kinase 2 (MAPKAPK2), Cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1) and Cytochrome P450, family 27, subfamily B, polypeptide 1 (CYP27B1) in the pathogenesis of TGCT. We demonstrate, for the first time, that primary TGCT as well as TGCT cell lines, express VDR mRNA and protein. Vitamin D and VDR may play a role in the pathogenesis of TGCTs. Furthermore, vitamin D inhibits proliferation of TGCT cell-lines, potentially via an increase in expression of GADD45. Our data suggest that vitamin D could play a role in antitumour therapy.


Subject(s)
Biomarkers, Tumor/metabolism , Neoplasms, Germ Cell and Embryonal/metabolism , Neoplasms, Germ Cell and Embryonal/pathology , Receptors, Calcitriol/metabolism , Testicular Neoplasms/metabolism , Testicular Neoplasms/pathology , Adult , Biomarkers, Tumor/genetics , Blotting, Western , Cell Proliferation , Humans , Immunoenzyme Techniques , Male , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Receptors, Calcitriol/genetics , Signal Transduction , Vitamin D/analogs & derivatives , Vitamin D/pharmacology
7.
J Pathol ; 213(1): 72-81, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17590861

ABSTRACT

Testicular germ cell tumours (TGCT) represent the most common malignancy in young males. We reported previously that two prototype members of the mitogen-activated protein kinase (MAPK) family, the MAPK ERK kinase (MEK) and extracellular signal-regulated kinase (ERK), are inactive in malignant testicular germ cells and become active after drug stimulation, leading to apoptosis of tumour cells. In this study, we asked whether the protein phosphatase PP2A, a known inhibitor of the MEK-ERK pathway, participates in the proliferation and/or apoptosis of primary TGCT (n = 48) as well as two TGCT cell lines (NTERA and NCCIT). Quantitative RT-PCR, immunohistochemistry, western blot analyses and phosphatase assay indicate that primary TGCT as well as TGCT cell lines express PP2A and that PP2A is active in TGCT cell lines. The inhibition of PP2A by application of two PP2A inhibitors, cantharidic acid (CA) and okadaic acid (OA), results in a significant increase in caspase-3-mediated apoptosis of TGCT cell lines. Thereby, PP2A inhibition was accompanied by phosphorylation and activation of MEK and ERK. Functional assays using the MEK inhibitor PD98059 demonstrated that the phosphorylation of MEK and ERK was required for the induction of caspase-3-mediated apoptosis of malignant germ cells. Thus, our data suggest that inhibition of PP2A mediates its apoptosis-inducing effect on TGCT through activation of the MEK-ERK signalling pathway that leads to caspase-3-mediated apoptosis of tumour cells. In addition our results support previous observations that PP2A exerts an anti-apoptotic effect on malignant tumour cells.


Subject(s)
Neoplasms, Germ Cell and Embryonal/enzymology , Protein Phosphatase 2/analysis , Testicular Neoplasms/enzymology , Adult , Aged , Apoptosis/drug effects , Blotting, Western/methods , Cantharidin/pharmacology , Caspase 3/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Enzyme Activation , Extracellular Signal-Regulated MAP Kinases/metabolism , Flavonoids/pharmacology , Humans , Immunohistochemistry , Male , Middle Aged , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Okadaic Acid/pharmacology , Phosphorylation , Protein Phosphatase 2/antagonists & inhibitors , Protein Phosphatase 2/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Staining and Labeling
8.
Gut ; 55(2): 220-7, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16118351

ABSTRACT

BACKGROUND AND AIMS: Activation of T cells by dendritic cells (DC) is thought to play a pivotal role in induction and maintenance of Crohn's disease. Detailed analyses however concerning the phenotype and maturation of DC as well as the mechanisms underlying their recruitment are still lacking for Crohn's disease. METHODS: Different myeloid and plasmacytoid DC subsets were characterised by immunohistochemistry. Expression of the so-called "lymphoid" chemokines CCL19, CCL20, and CCL21 was determined by real time reverse transcription-polymerase chain reaction in Crohn's disease and normal controls. Furthermore, expression of CCL19, CCL20, and CCL21 as well as their receptors CCR6 (for CCL20) and CCR7 (for CCL19 and CCL21) was characterised by immunohistochemistry and, in addition, their cellular localisation was determined by double immunofluorescence investigations. RESULTS: Colonic tissue affected by Crohn's disease was characterised by an increased number of mature myeloid DC forming clusters with proliferating T cells. In keeping with their advanced maturation, DC possess the chemokine receptor CCR7. Increased expression of the CCR7 ligands CCL19 by DC themselves as well as CCL21 by reticular cells and lymphatic vessels was observed in Crohn's disease, thereby causing the matured DC to be trapped at the site of inflammation. CONCLUSION: Our results demonstrate that autocrine and paracrine actions of lymphoid chemokines in Crohn's disease may lead to increased numbers of mature DC away from their usual migration to lymphoid organs and result in the development of a tertiary lymphatic tissue within the bowel wall maintaining the autoimmune inflammation in Crohn's disease.


Subject(s)
Chemokines/immunology , Crohn Disease/immunology , Dendritic Cells/immunology , Adolescent , Adult , Aged , Autocrine Communication/immunology , Chemokine CCL19 , Chemokine CCL20 , Chemokine CCL21 , Chemokines, CC/analysis , Colon/immunology , Humans , Immunoenzyme Techniques , Macrophage Inflammatory Proteins/analysis , Middle Aged , Paracrine Communication/immunology , Receptors, CCR7 , Receptors, Chemokine/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods
9.
Int J Oncol ; 25(6): 1671-6, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15547704

ABSTRACT

Testicular germ cell tumours (TGCT) are the most common solid tumour among young males. Whereas in 1970s, only 5% of patients with a metastatic testicular tumours survived their disease, these days 80% of patients treated by modern cisdiamminedichloroplatinum (cisplatin, CDDP)-based chemotherapy are cured. Although data are accumulating on the effect of the mitogen-activated protein kinase (MAPK) family on the CDDP-induced apoptosis in tumour cells, the mechanisms by which CDDP initiates apoptosis in TGCT are not completely understood. Applying Western blot and phosphorylated kinase-specific ELISA analyses, flow cytometry, blocking experiments, and morphological methods we sought here to define the MAPK pathway(s) involved in the CDDP-induced apoptosis in the human TGCT cell line NCCIT. Our experiments showed that within hours of CDDP application only the extracellular signal-regulated kinase (ERK) was dually phosphorylated and caspase-3 became active. Functional assays using chemical inhibitors demonstrated that the phosphorylation of ERK was mediated by reactive oxygen species in an Raf-1-independent manner and required the activation of caspase-3. Thus, our data suggest that CDDP mediates its apoptosis-inducing effect on the human malignant testicular germ cells, at least partially, through activation of the MEK-ERK signaling pathway in a ROS-dependent, Raf-1-independent manner.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Cisplatin/pharmacology , Neoplasms, Germ Cell and Embryonal/pathology , Reactive Oxygen Species/adverse effects , Testicular Neoplasms/pathology , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Humans , MAP Kinase Kinase Kinases/pharmacology , Male , Mitogen-Activated Protein Kinase Kinases/pharmacology , Phosphorylation , Tumor Cells, Cultured
10.
Br J Cancer ; 91(3): 589-98, 2004 Aug 02.
Article in English | MEDLINE | ID: mdl-15266324

ABSTRACT

Testicular germ cell tumours (TGCT) represent the most common malignancies in young males. Whereas in 1970s, the survival rate in patients with metastatic testicular tumours was only 5%, these days, 80% of the patients treated by modern chemotherapy will survive their disease. The drug that revolutionised the cure rate for patients with metastatic testicular tumours was cisdiamminedichloroplatinum (cisplatin, CDDP). In vitro experiments on neoplastic germ cell lines showed that their exquisite sensitivity to CDDP could be attributed to p53-dependent and -independent pathways. Applying cDNA macroarray, semiquantitative RT-PCR and Western blot analyses, blocking experiments, caspase activity assays, and morphological methods, we sought here to define the p53-independent pathway(s) involved in the CDDP-induced apoptosis. For this purpose, we used the human TGCT cell line NCCIT, the mutated p53 of which is known to remain inactive during the course of CDDP-induced apoptosis. Our experiments showed that within hours of CDDP application, two prototype members of the 'mitogen-activated protein kinase' (MAPK) family, designated 'MAPK ERK kinase' (MEK) and 'extracellular signal-regulated kinase' (ERK), were dually phosphorylated and caspase-3 became active. Functional assays using MEK inhibitors demonstrated that the phosphorylation of MEK and ERK was required for the activation of caspase-3 as the executing caspase. Interestingly, experiments with the human malignant germ cell line NTERA, which is known to possess wild-type p53, revealed the same results. Thus, our data suggest that CDDP mediates its p53-independent apoptosis-inducing effect on the malignant human testicular germ cells--at least partially--through activation of the MEK-ERK signalling pathway. July 2004


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cisplatin/pharmacology , Gene Expression Profiling , Genes, p53 , MAP Kinase Signaling System/physiology , Mitogen-Activated Protein Kinase Kinases/biosynthesis , Neoplasms, Germ Cell and Embryonal/pathology , Testicular Neoplasms/pathology , Blotting, Western , Cell Cycle , Humans , Male , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinase Kinases/pharmacology , Oligonucleotide Array Sequence Analysis , Phosphorylation , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Tumor Cells, Cultured
11.
Br J Cancer ; 89(5): 915-21, 2003 Sep 01.
Article in English | MEDLINE | ID: mdl-12942126

ABSTRACT

Cytokines possess discrepant effects on tumour cells varying from anti- to proapoptotic activities. We recently reported that testicular germ cell tumours (TGCT) express a functional form of the proinflammatory cytokine interferon-gamma (IFNgamma). The present study asked whether TGCT-derived IFNgamma influences survival or death of neoplastic germ cells. Analysis of TGCT cell lines demonstrated that they expressed and secreted IFNgamma, but were resistant to the endogenous IFNgamma since neutralisation of IFNgamma by a specific blocking antibody had no influence on the proliferation and/or the degree of apoptosis of tumour cells. To study mechanisms providing tumour resistance to endogenous IFNgamma, we analysed primary TGCT and two human TGCT cell lines (NTERA and NCCIT) for the expression of IFNgamma receptor and for the level of phosphorylation of the signal transducer and activator of transcription (STAT)-1. In situ hybridisation, immunocytochemistry, Western blot analysis and flow cytometry indicated that primary TGCT as well as NCCIT and NTERA cell lines expressed the heterodimeric cell surface IFNgamma receptor which consists of both 90-kDa alpha- and the 85-kDa beta-chains. However, the downstream transcription factor STAT-1 was not phosphorylated constitutively, indicating that STAT-1 is not activated by the endogenous IFNgamma. Upon application of recombinant human IFNgamma in excess, however, STAT-1 was phosphorylated and the interferon regulatory factor-1 (IRF-1) was induced, suggesting that both IFNgammaR and STAT-1 are functionally intact in TGCT. Altogether our results suggest that despite secreting biologically active IFNgamma, the concentration of the endogenous IFNgamma is too low to stimulate the IFNgammaR/STAT signalling pathway in TGCT in an autocrine and/or paracrine manner.


Subject(s)
DNA-Binding Proteins/metabolism , Germinoma/metabolism , Interferon-gamma/metabolism , Receptors, Interferon/biosynthesis , Testicular Neoplasms/metabolism , Trans-Activators/metabolism , Apoptosis , Blotting, Western , DNA, Complementary/analysis , DNA-Binding Proteins/chemistry , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Gene Expression Regulation, Neoplastic , Germinoma/genetics , Germinoma/pathology , Humans , Immunohistochemistry , In Situ Hybridization , Interferon-gamma/genetics , Male , Phosphorylation , Receptors, Interferon/genetics , Reverse Transcriptase Polymerase Chain Reaction , STAT1 Transcription Factor , Testicular Neoplasms/genetics , Testicular Neoplasms/pathology , Trans-Activators/chemistry , Tumor Cells, Cultured , Interferon gamma Receptor
12.
J Pathol ; 197(1): 89-97, 2002 May.
Article in English | MEDLINE | ID: mdl-12081209

ABSTRACT

Tumour-infiltrating T lymphocytes (TILs) possess discrepant properties ranging from anti- to protumour activities. Understanding precisely which mechanisms navigating T lymphocytes into the tumour site will help to further the anti-tumour or to disrupt the pro-tumour activities of TILs. The present study asked what enables TILs to migrate into testicular germ cell tumours (TGCTs). TILs were characterized and the expression of a large panel of T-lymphocyte-attracting chemokines was investigated in 21 TGCT cases. Flow cytometry revealed that approximately 80% of TGCT-infiltrating T lymphocytes express CXCR3, a receptor for the chemokine interferon-inducible protein-10 (IP-10). RT-PCR and immunohistochemistry indicated that IP-10 was the only chemokine investigated which was constantly expressed in TGCT. As IP-10 was found to be expressed by endothelial cells of TGCT-associated blood vessels, the question arose whether the IP-10-regulating cytokine interferon-gamma (IFNgamma) is produced by tumour cells and if so, whether tumour-derived IFNgamma can induce IP-10 in endothelial cells. Applying in situ hybridization, IFNgamma transcripts were found in neoplastic germ cells. Analyses of two TGCT cell lines indicated that the tumour cells not only express IFNgamma mRNA, but also produce and secrete IFNgamma protein; tumour-derived IFNgamma provokes IP-10 expression and secretion by endothelial cells in vitro, as assessed by PCR and ELISA. Together, the data suggest that neoplastic germ cells secret IFNgamma and thereby stimulate tumour-associated endothelial cells to express IP-10, which contributes to the recruitment of CXCR3+ T lymphocytes to the site of TGCTs.


Subject(s)
Chemokines, CXC/metabolism , Lymphocytes, Tumor-Infiltrating/immunology , Neoplasms, Germ Cell and Embryonal/immunology , Testicular Neoplasms/immunology , Adult , Chemokine CXCL10 , Chemotaxis, Leukocyte/immunology , Endothelium, Vascular/immunology , Gene Expression , Humans , In Situ Hybridization , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Male , Middle Aged , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Receptors, CXCR3 , Receptors, Chemokine/metabolism , Tumor Cells, Cultured
13.
Gut ; 49(6): 795-803, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11709514

ABSTRACT

BACKGROUND: The mechanisms involved in the initiation and maintenance of Crohn's disease are poorly understood. Previous studies have demonstrated an increased number of infiltrating CD4+ T cells within the inflammatory affected bowel wall in Crohn's disease. Novel therapy approaches using anti-CD4 antibodies are thought to be effective in Crohn's disease. AIMS: Interleukin 16 (IL-16) has been characterised as a chemokine with selective chemoattraction for CD4+ inflammatory T cells. In this study, cellular expression of IL-16 in Crohn's disease and ulcerative colitis was investigated. METHODS: Expression of IL-16 was analysed in tissue samples of Crohn's disease, ulcerative colitis, and normal controls by applying reverse transcription-polymerase chain reaction, non-radioactive in situ hybridisation, and immunohistochemistry. Double staining methods were used to characterise cells expressing IL-16. The amount of infiltrating CD4+ cells was determined by immunohistochemistry and correlated with the corresponding IL-16+ cell number by step sections. RESULTS: An increased number of IL-16+ cells in Crohn's disease in comparison with ulcerative colitis and control probes was demonstrated. IL-16 was expressed by CD4 and CD8 positive T cells. In addition, in active Crohn's disease there was a substantial number of IL-16 positive mast cells. The increased number of CD4+ lymphocytes correlated positively with the increased number of IL-16 positive cells in Crohn's disease. CONCLUSION: Our results demonstrate that increased expression of IL-16 in T cells and mast cells in active Crohn's disease is associated with increased numbers of CD4+ lymphocytes. Local expression of IL-16 seems to play a significant role in the initiation and persistence of the inflammatory process in Crohn's disease, presumably by IL-16 mediated recruitment of CD4+ cells, mostly lymphocytes, into the bowel wall.


Subject(s)
Crohn Disease/immunology , Interleukin-16/analysis , T-Lymphocytes/immunology , Adolescent , Adult , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Chemotaxis, Leukocyte , Colitis, Ulcerative/immunology , Colon/immunology , Female , Humans , Immunohistochemistry/methods , In Situ Hybridization/methods , Male , Mast Cells/immunology , Middle Aged , Phenotype , Reverse Transcriptase Polymerase Chain Reaction
14.
Am J Pathol ; 159(5): 1751-61, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11696436

ABSTRACT

Recruitment of lymphocytes is a prominent feature of the inflammatory process in Crohn's disease (CD). The present study was undertaken to investigate the expression of the novel lymphocyte-specific chemoattractant lymphotactin (Lptn) as a potential regulatory factor for the recruitment of T cells in CD. The expression of Lptn mRNA was quantified in resection specimens of patients with CD in comparison to normal controls without signs of inflammation by real-time quantitative reverse transcriptase-polymerase chain reaction and localized by nonradioactive in situ hybridization. Furthermore, the phenotype of cells expressing Lptn mRNA was characterized. In contrast to normal controls Lptn mRNA was significantly increased in tissue samples affected by CD. Cells expressing Lptn were identified as T cells, mast cells, and unexpectedly dendritic cells. Lptn mRNA was found to be up-regulated on stimulation with phorbol-12-myristate-13-acetate and concanavalin A in T cells isolated from peripheral blood, which could be prevented by dexamethasone, cyclosporine A, and FK506. A similar regulation mechanism could be identified for the Lptn receptor GPR-5 in peripheral T cells. In addition, Lptn mRNA expression could be induced in mature monocyte-derived dendritic cells. The results indicate that local expression of Lptn by activated T cells and to a lesser extent by mast cells and dendritic cells represents a key regulator for lymphocyte trafficking and maintenance of the inflammatory process observed in CD, which might be partly mediated through an autocrine/paracrine pathway of activated T cells.


Subject(s)
Chemokines, C , Crohn Disease/metabolism , Lymphokines/metabolism , Membrane Proteins , Receptors, G-Protein-Coupled , Sialoglycoproteins/metabolism , T-Lymphocytes/physiology , Cell Differentiation , Cells, Cultured , Crohn Disease/pathology , Crohn Disease/physiopathology , Dendritic Cells/metabolism , Humans , Lymphokines/genetics , Monocytes/cytology , RNA, Messenger/metabolism , Receptors, Cell Surface/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sialoglycoproteins/genetics , Tissue Distribution
15.
Cytokine ; 13(4): 227-33, 2001 Feb 21.
Article in English | MEDLINE | ID: mdl-11237430

ABSTRACT

Malignant tumours are usually accompanied by an immune response. Chemokines such as MCP-1 have been claimed to be potent inducers of such tumour-associated reactions. In the present study MCP-1 mRNA was quantified by competitive reverse transcription polymerase reaction and localised by in situ hybridisation in renal cell carcinoma tissue in comparison to tumour-free tissue of the same nephrectomy specimen. MCP-1 mRNA levels were correlated with the immune cell infiltrate, the density of CD31(+)microvessels, and the endothelial expression of ICAM-1, VCAM-1, E-, and P-selectin. In only seven of 19 cases, MCP-1 mRNA levels in carcinoma tissue were increased in comparison to tumour-free tissue. Within tumour tissue, mRNA transcripts could be localised in tumour cells, microvessel endothelia, and in tumour-associated macrophages. A correlation between MCP-1 mRNA levels and the density of immune cells, especially macrophages, the microvessel density, and the expression of adhesion molecules could not be observed. Therefore, MCP-1 seems to be of minor importance for the induction of an immune response in renal cell carcinomas regarding at least the parameters analysed in this study.


Subject(s)
Carcinoma, Renal Cell/immunology , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , In Situ Hybridization , Kidney Neoplasms/immunology , RNA, Messenger/metabolism , Carcinoma, Renal Cell/blood supply , Carcinoma, Renal Cell/chemistry , Carcinoma, Renal Cell/pathology , Cell Adhesion Molecules/biosynthesis , Chemokine CCL2/biosynthesis , Humans , Kidney/blood supply , Kidney/chemistry , Kidney/immunology , Kidney/pathology , Kidney Neoplasms/blood supply , Kidney Neoplasms/chemistry , Kidney Neoplasms/pathology , Microcirculation/immunology , Microcirculation/pathology , Neutrophil Infiltration/immunology , RNA, Messenger/biosynthesis
16.
Virchows Arch ; 439(5): 645-52, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11764385

ABSTRACT

Rapidly growing tumors often develop necrosis. In the present study the expression of vascular endothelial growth factor (VEGF) was investigated and compared to microvessel density and necrosis of renal cell carcinomas. In the tumor-host interface the microvessel density was significantly increased compared to central tumor areas. Tumor necrosis was associated with a decrease of microvessel density and an increase of the VEGF protein expression within the perinecrotic rim. VEGF protein was focally upregulated in vital tumor tissue. An increase of the apoptotic rate of endothelia and vital tumor tissue in tumors with necrosis could not be detected. VEGF(121,165) mRNA was decreased in proliferatively active carcinomas compared to less proliferative tumors. Multicellular renal cell cancer spheroids as a model of chronic hypoxia developed central apoptosis but no necrosis. VEGF was upregulated in the spheroid. Tumor microvessels expressed matrix metalloproteinase -2 and -9 and an incomplete pericyte covering in comparison to tumor-free tissue indicating immature active angiogenesis. We conclude that highly proliferative renal cell carcinomas outgrow their vascular supply and develop chronic hypoxia inducing a decrease of proliferation and an increase of VEGF expression. However, chronic hypoxia does not cause significant necrosis or apoptosis. Tumor necrosis is more likely induced by acute hypoxia due to immature microvessels. Furthermore, VEGF expression associated with concomitant tumor necrosis may help identify renal cell carcinomas susceptible to antiangiogenic therapy.


Subject(s)
Carcinoma, Renal Cell/metabolism , Endothelial Growth Factors/biosynthesis , Kidney Neoplasms/metabolism , Lymphokines/biosynthesis , Neovascularization, Pathologic/metabolism , Antigens, Nuclear , Apoptosis , Carcinoma, Renal Cell/blood supply , Carcinoma, Renal Cell/pathology , Cell Division , Endothelial Growth Factors/genetics , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Humans , Immunohistochemistry , In Situ Hybridization , In Situ Nick-End Labeling , Kidney Neoplasms/blood supply , Kidney Neoplasms/pathology , Lymphokines/genetics , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 9/biosynthesis , Matrix Metalloproteinase 9/genetics , Microcirculation , Necrosis , Nuclear Proteins/analysis , Pericytes/metabolism , Pericytes/pathology , Platelet Endothelial Cell Adhesion Molecule-1/analysis , RNA, Messenger/analysis , RNA, Neoplasm/analysis , Reverse Transcriptase Polymerase Chain Reaction , Spheroids, Cellular/metabolism , Spheroids, Cellular/pathology , Tumor Cells, Cultured , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
17.
Arch Dermatol Res ; 292(8): 384-90, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10994772

ABSTRACT

Granuloma annulare, a prototype noninfectious granulomatous dermatitis, is morphologically characterized by a necrobiotic core surrounded by a cellular infiltrate. Because of many morphological similarities to tuberculosis, granuloma annulare has been suggested to represent a delayed-type hypersensitivity (Th1) reaction in the course of which inflammatory cells elicit matrix degradation. In the present study we (1) investigated the expression of interferon-gamma as the most important Th1-associated cytokine, (2) sought in situ evidence for the coexpression of the proinflammatory cytokine tumor necrosis factor-alpha and cytokine-regulated matrix metalloproteinases 2 (gelatinase A) and 9 (gelatinase B), and (3) sought to determine whether shrunken cells seen within necrobiotic areas of granuloma annulare are apoptotic cells. In situ hybridization combined with immunofluorescence showed that large numbers of infiltrating CD3+ lymphocytes express interferon-gamma. Application of catalyzed signal amplification in immunodetection revealed that the vast majority of CD3+ lymphocytes and CD68+ macrophages contained tumor necrosis factor-alpha. Immunohistochemistry demonstrated that macrophages producing tumor necrosis factor-alpha coexpress matrix metalloproteinases 2 and 9. In situ end-labeling combined with immunofluorescence detected few apoptotic T cells in perivascular regions and numerous apoptotic macrophages within necrobiotic areas. These results suggest that in granuloma annulare interferon-gamma+ Th-1 lymphocytes may cause a delayed-type hypersensitivity reaction whereby macrophages are differentiated to aggressive effector cells expressing tumor necrosis factor-alpha and matrix metalloproteinases. In parallel, activation-induced apoptosis in lymphocytes and macrophages may serve to restrict the destructive potential of the inflammatory cells.


Subject(s)
Apoptosis/physiology , Granuloma Annulare/metabolism , Interferon-gamma/metabolism , Macrophages/physiology , Matrix Metalloproteinases/metabolism , T-Lymphocytes/physiology , Tumor Necrosis Factor-alpha/metabolism , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , CD3 Complex/analysis , Granuloma Annulare/pathology , Granuloma Annulare/physiopathology , Humans , Leukocyte Common Antigens/analysis , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinases/immunology
18.
Anticancer Res ; 20(3A): 1781-5, 2000.
Article in English | MEDLINE | ID: mdl-10928107

ABSTRACT

Proliferative compartments of a tumour can be determined cytophotometrically, by in situ hybridisation or by immunohistochemical detection of Ki67 antigen. The main objective of this study was to analyse the proliferative activity during the progression of pigmented skin lesions with respect to differential diagnostic and prognostic applications. The material investigated consisted of 209 pigmented skin lesions (31 naevi, 30 dysplastic naevi, 106 primary melanomas, 20 lymphatic and 22 organ melanoma metastases). Comparison of the ratios of cells in the S-phase gained by two different methods (cytometry, in situ hybridisation) did not show any significant differences. The correlations between Ki67 and S-phase indices in every diagnostic group were highly significant. The results of forward and backward Cox regression were identical and only Ki67 showed an independent prognostic influence (p < 0.001, coefficient in regression 0.02) with change in risk 2% and confidence limit ranging between 1.1% and 2.9%.


Subject(s)
Pigmentation Disorders/pathology , Skin Neoplasms/pathology , Skin/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Cell Division , Child , Diagnosis, Differential , Disease Progression , Female , Humans , Ki-67 Antigen/analysis , Male , Melanoma/diagnosis , Melanoma/immunology , Melanoma/mortality , Melanoma/pathology , Middle Aged , Pigmentation Disorders/diagnosis , Prognosis , Regression Analysis , S Phase , Skin/immunology , Skin Neoplasms/diagnosis , Survival Analysis
19.
J Pathol ; 191(4): 417-25, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10918217

ABSTRACT

Immunity against mycobacteria is almost exclusively confined to epithelioid cell granulomas, where a long-lasting but labile balance exists between host and bacilli. The relationship between immunity and mycobacteria results in regression, growth, or caseation of granulomas. To prove whether caseation is associated with apoptosis, biopsy specimens of patients with tuberculosis were analysed by electron microscopy and by in situ end-labelling combined with immunofluorescence. Apoptotic cells were not detected in regressive granulomas. Whereas productive granulomas without histologically recognizable caseous necrosis revealed only single apoptotic cells, large numbers of apoptotic CD68+ macrophages and apoptotic CD3+, CD45RO+ T cells were observed within caseous foci. As prime candidates undergoing and/or eliciting apoptosis, vital cells surrounding caseous foci were characterized. Immunohistochemistry showed that the majority of vital CD68+ macrophages surrounding caseous foci are negative for the anti-apoptotic protein bcl2, but positive for the pro-apoptotic protein bax. In situ hybridization combined with immunofluorescence demonstrated that the majority of the adjacent lymphocytes are activated CD3+, CD45RO+ cells expressing the pro-inflammatory cytokine interferon gamma (IFN gamma) and the death ligand FasL. These results suggest that caseation is strongly associated with apoptosis of macrophages and T lymphocytes; that the onset of apoptosis in macrophages may be promoted by the lack of bcl2 and the abundance of bax; and that activation-induced cell death (AICD) may be responsible for the apoptosis of T cells.


Subject(s)
Apoptosis/physiology , Macrophages/pathology , T-Lymphocytes/pathology , Tuberculosis/pathology , CD3 Complex/metabolism , Female , Fluorescent Antibody Technique , Humans , In Situ Hybridization , In Situ Nick-End Labeling , Interferon-gamma/biosynthesis , Leukocyte Common Antigens/metabolism , Male , Microscopy, Electron , Necrosis , Proto-Oncogene Proteins c-bcl-2/analysis , Tuberculoma/pathology , fas Receptor/metabolism
20.
Histopathology ; 37(1): 78-83, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10931222

ABSTRACT

AIMS: Neoangiogenesis is accompanied by an increase in endothelial surface, which can support infiltration by immune cells depending on adhesion molecule expression. Therefore, the expression of cell adhesion molecules on microvessels and epithelial cells was analysed in renal cell carcinomas as compared to tumour-free tissue. METHODS AND RESULTS: PECAM-1, CD34, ICAM-1, VCAM-1, VLA-4, P- and E-selectin, the macrophage antigens Ki-M1P and Mac-1, and lymphocyte function antigen LFA-1 were identified immunohistochemically. VCAM-1, ICAM-1, and E-selectin were equally or less expressed, whereas P-selectin was increased on microvessels in tumour tissue. The density of VCAM-1-positive tumour microvessels correlated positively with an advanced tumour stage and E- and P-selectin-positive tumour microvessels with the amount of associated macrophages. The expression of ICAM-1 and VCAM-1 on neoplastic epithelia correlated with an increased density of macrophages and a minor degree of tumour differentiation. CONCLUSIONS: The positive correlation of macrophage infiltration and expression of cell adhesion molecules on tumour microvessels and epithelia with minor tumour differentiation and an advanced stage indicates that adhesion molecule expression is not associated with an effective antitumour function of macrophages


Subject(s)
Carcinoma, Renal Cell/metabolism , Cell Adhesion Molecules/metabolism , Kidney Neoplasms/metabolism , Carcinoma, Renal Cell/blood supply , Carcinoma, Renal Cell/pathology , E-Selectin/metabolism , Epithelium/metabolism , Humans , Immunohistochemistry , Intercellular Adhesion Molecule-1/metabolism , Kidney Neoplasms/blood supply , Kidney Neoplasms/pathology , Macrophages , Microcirculation , P-Selectin/metabolism , Vascular Cell Adhesion Molecule-1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...